NLRP3 and atrial fibrillation: The parallel involvement of both NLRP3 and AIM2 inflammasomes in maladaptive atrial remodeling underscores their potential as upstream regulators of proarrhythmic signaling cascades and supports their candidacy as novel therapeutic targets in the prevention and management of AF.